PL2010528T3

6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting csf-1r signaling

Abstract

Benzoxazole and benzothiazole compounds and the stereoisomers, tautomers, solvates, oxides, esters, and prodrugs thereof and pharmaceutically acceptable salts thereof are disclosed. Compositions of the compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier, and uses of the compounds, either alone or in combination with at least one additional therapeutic agent are also disclosed. The embodiments are useful for inhibiting cellular proliferation, inhibiting the growth and/or metathesis of tumors, treating or preventing cancer, treating or preventing degenerating bone diseases such as rheumatoid arthritis, and/or inhibiting molecules such as CSF-1R.

Term

0.6 yearsto projected expiry

Projected expiry 18 April 2027, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

47 members in 32 offices

This recordMember, by publication datePriority claim22 more offices are in the list below

Priority claims14

Priority claims
DocumentOfficeKindDate
79351706United States of AmericaP
79351706United States of AmericaP
89385707United States of AmericaP
89385707United States of AmericaP
07797244European Patent Office (EPO)A
2007066898United States of AmericaW
2007066898United States of AmericaW
077972446
793517P
893857P
EP20070797244
US20060793517P
US20070893857P
WO2007US66898

Members47

Family members, oldest first
DocumentOfficeKind
AU2007237904A1AustraliaA1
CA2649288A1CanadaA1
WO2007121484A2World Intellectual Property Organization (WIPO)A2
WO2007121484A3World Intellectual Property Organization (WIPO)A3
US2008045528A1United States of AmericaA1
TW200813039ATaiwan Province of ChinaA
PE20080359A1PeruA1
AR060545A1ArgentinaA1
MX2008013427AMexicoA
NO20084800LNorwayL
SMAP200800063ASan MarinoA
ECSP088830AEcuadorA
KR20080112388ARepublic of KoreaA
CR10365ACosta RicaA
EP2010528A2European Patent Office (EPO)A2
EA200802129A1Eurasian Patent Organization (EAPO)A1
MA30407B1MoroccoB1
CN101432281AChinaA
ZA200808105BSouth AfricaB
US7553854B2United States of AmericaB2
IL194662D0IsraelD0
JP2009534410AJapanA
SMP200800063BSan MarinoB
TNSN08406A1TunisiaA1
US2010280006A1United States of AmericaA1
AU2007237904B2AustraliaB2
BRPI0710540A2BrazilA2
US8173689B2United States of AmericaB2
US2012225861A1United States of AmericaA1
CN101432281BChinaB
JP5328640B2JapanB2
EA018917B1Eurasian Patent Organization (EAPO)B1
US8710048B2United States of AmericaB2
KR101464385B1Republic of KoreaB1
CA2649288CCanadaC
EP2010528B1European Patent Office (EPO)B1
PT2010528TPortugalT
LT2010528TLithuaniaT
DK2010528T3DenmarkT3
HRP20171924T1CroatiaT1
ES2654847T3SpainT3
RS56600B1SerbiaB1
SI2010528T1SloveniaT1
PL2010528T3This recordPolandT3
CY1119679T1CyprusT1
HUE035654T2HungaryT2
BRPI0710540B1BrazilB1